V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10380090 | 10064720 | 1.54 | 60.6 | Adjuvant (A) | 2019-12-21 | 2020-01-11 | CABOZANTINIB | 02 | N | CISPLATIN + GEMCITABINE | 100496821 |
| 10380491 | 10064722 | 1.85 | 91.8 | Palliative (P) | 2022-03-04 | 2022-03-04 | Acalabrutinib | 02 | N | CABOZANTINIB | 100357870 |
| 10380513 | 10064723 | 1.88 | 99.3 | null | 2016-12-07 | 2016-12-10 | DABRAFENIB + TRAMETINIB | 02 | null | DABRAFENIB + TRAMETINIB | 101129962 |
| 10380779 | 10064726 | 1.75 | 106 | null | null | 2022-05-01 | Methotrexate High Dose (3g/m2) | 02 | null | METHOTREXATE | 101083140 |
| 10381044 | 10064727 | 1.82 | 86.45 | null | 2020-09-27 | 2020-09-29 | Cisplatin + Vinorelbine (IV) | 02 | null | DABRAFENIB | 100273237 |
| 10381113 | 10064728 | 1.61 | 75.4 | 03 | 2016-12-19 | 2018-09-18 | Trifluridine + Tipiracil | 02 | N | TIPIRACIL + TRIFLURIDINE | 101216699 |
| 10381245 | 10064730 | 1.59 | 69.1 | null | 2022-04-06 | 2022-04-19 | Cabazitaxel | null | null | CABAZITAXEL | 100594412 |
| 10381607 | 10064731 | 1.75 | 57.5 | Palliative (P) | 2017-05-08 | 2017-05-17 | Fluorouricil + Folonic Acid (MdG) | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100997509 |
| 10381617 | 10064732 | 1.75 | 54.5 | null | 2019-09-08 | 2019-09-09 | Azacitidine | 02 | null | AZACITIDINE | 101270869 |
| 10382031 | 10064734 | 1.69 | null | Palliative (P) | 2019-08-09 | 2019-12-30 | Methotrexate High Dose (3g/m2) | 02 | N | METHOTREXATE | 101623011 |
| 10382128 | 10064735 | 1.85 | 70 | Palliative (P) | 2018-10-25 | 2018-10-25 | Bortezomib + Panobinostat | 02 | N | BORTEZOMIB + PANOBINOSTAT | 100329831 |
| 10382199 | 10064736 | 1.53 | null | Palliative (P) | 2020-01-04 | 2020-05-16 | null | 02 | N | VINORELBINE | 100451734 |
| 10382751 | 10064738 | 1.68 | 0 | Disease modification (D) | 2021-02-28 | 2021-03-04 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 100074279 |
| 10382905 | 10064739 | 1.62 | 67.7 | null | 2020-07-09 | 2020-08-30 | Cyclophosphamide oral | 02 | null | CYCLOPHOSPHAMIDE | 101547792 |
| 10382941 | 10064740 | 1.54 | 84.5 | null | 2021-04-19 | 2021-05-17 | FLUOROURACIL | 02 | null | CAPECITABINE + IRINOTECAN | 100631479 |
| 10383005 | 10064741 | 1.72 | 0 | Not known (9) | 2020-06-29 | 2021-01-29 | Cisplatin + Vinorelbine (IV) | 2 | N | CAPECITABINE + IRINOTECAN | 101551163 |
| 10383158 | 10064744 | null | 71 | null | 2019-08-14 | 2019-08-21 | FLUOROURACIL | 02 | null | CISPLATIN + GEMCITABINE | 100700369 |
| 10383758 | 10064747 | 1.68 | 56.55 | null | 2018-02-16 | 2018-02-23 | Gemcitabine 1000mg/m2 D1 8 15 | null | null | GEMCITABINE | 100732005 |
| 10383819 | 10064748 | 1.79 | 72.9 | null | 2020-09-01 | 2020-09-04 | AFATINIB | 02 | null | AFATINIB | 100441465 |
| 10384006 | 10064750 | 1.72 | 91.4 | 03 | 2017-12-18 | 2017-12-23 | CARBOPLATIN + VINORELBINE | 02 | N | CARBOPLATIN + VINORELBINE | 101054517 |
| 10384137 | 10064752 | null | 100 | Palliative (P) | 2020-09-30 | 2020-10-08 | Cisplatin + Radiotherapy | 02 | N | ACALABRUTINIB | 101193089 |
| 10384229 | 10064753 | 1.74 | 73.8 | null | 2021-04-21 | 2021-07-18 | CABOZANTINIB | 02 | null | CETUXIMAB | 100522811 |
| 10384319 | 10064754 | null | 118 | null | 2019-11-10 | 2019-11-11 | Chlorambucil | 02 | null | CHLORAMBUCIL | 100176167 |
| 10384452 | 10064755 | 1.58 | 59.9 | Palliative (P) | 2017-12-11 | 2019-06-19 | Bortezomib + Panobinostat | 02 | N | BORTEZOMIB + PANOBINOSTAT | 101506952 |
| 10384537 | 10064757 | 1.74 | 71.9 | 02 | 2021-06-19 | 2021-12-14 | Bortezomib + Panobinostat | 02 | N | BORTEZOMIB + PANOBINOSTAT | 101390387 |
| 10384939 | 10064759 | 1.72 | 53.7 | null | 2017-12-23 | 2017-12-23 | BUSULFAN | null | null | CISPLATIN + GEMCITABINE | 100235927 |
| 10385116 | 10064760 | 1.76 | 77 | Curative (C) | 2020-12-28 | 2021-01-01 | Melphalan IV High dose | 02 | null | MELPHALAN | 101000241 |
| 10385524 | 10064761 | 1.78 | 95.6 | Palliative (P) | 2019-11-25 | 2020-01-16 | Acalabrutinib | 02 | N | BUSULFAN | 100116411 |
| 10385774 | 10064762 | 1.78 | 65.3 | null | 2021-06-25 | 2021-06-25 | DABRAFENIB + TRAMETINIB | 02 | null | DABRAFENIB + TRAMETINIB | 101162058 |
| 10385898 | 10064763 | 1.71 | 64.9 | 03 | 2016-08-25 | 2016-09-01 | Palbociclib | 02 | N | PALBOCICLIB | 101113605 |
| 10386123 | 10064765 | 1.7 | 0 | Palliative (P) | 2017-12-12 | 2017-12-12 | Cisplatin + Vinorelbine (PO) | 02 | N | CISPLATIN + VINORELBINE | 101063711 |
| 10386166 | 10064766 | 1.84 | 114 | Palliative (P) | 2019-10-02 | 2019-10-21 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 101572943 |
| 10386259 | 10064767 | 1.2 | 59.3 | null | 2020-01-08 | 2020-01-17 | BORTEZOMIB + THALIDOMIDE | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100045841 |
| 10386265 | 10064768 | 1.75 | 65 | Palliative (P) | 2020-03-13 | 2020-03-13 | Niraparib | 02 | Y | DABRAFENIB | 101452827 |
| 10386670 | 10064770 | 1.59 | 65.5 | null | 2019-05-31 | 2019-05-31 | Methotrexate intrathecal | 02 | null | METHOTREXATE | 101070837 |
| 10387021 | 10064772 | 1.6 | 59 | Palliative (P) | 2018-12-22 | 2018-12-22 | CYCLOPHOSPHAMIDE + FILGRASTIM | 02 | Y | CYCLOPHOSPHAMIDE | 100778654 |
| 10387213 | 10064773 | 1.66 | 68 | Palliative (P) | 2018-12-20 | 2020-05-15 | Carboplatin + Liposomal Doxorubicin | 99 | N | FLUOROURACIL | 100444504 |
| 10387287 | 10064774 | 1.77 | 57.7 | null | 2021-05-17 | 2022-02-13 | GEMCITABINE | 02 | null | GEMCITABINE | 100832387 |
| 10387455 | 10064775 | 1.74 | 86.4 | Palliative (P) | 2019-12-02 | 2020-07-31 | Cabazitaxel | 02 | N | CABAZITAXEL | 100642170 |
| 10387611 | 10064777 | 1.86 | 124 | null | 2017-10-10 | 2018-09-23 | CTD Attenuated (Thalidomide 50mg) | 02 | N | ACALABRUTINIB | 100167365 |
| 10387807 | 10064778 | 1.59 | 74 | null | 2019-01-31 | 2019-03-13 | CETUXIMAB | 02 | null | DABRAFENIB | 100494608 |
| 10387965 | 10064779 | 1.8 | 65 | null | 2021-02-25 | 2021-03-04 | Bortezomib +/- Dexamethasone | N | null | BORTEZOMIB | 101679067 |
| 10388184 | 10064781 | 1.75 | 63.25 | Palliative (P) | 2020-01-14 | 2020-09-02 | Cabazitaxel | 99 | N | CABAZITAXEL | 100641963 |
| 10388212 | 10064782 | null | 69.7 | null | 2021-01-03 | 2021-01-03 | Vinorelbine IV | 02 | null | ACALABRUTINIB | 100539760 |
| 10388255 | 10064783 | null | 69.7 | null | null | 2022-04-29 | Palbociclib | 02 | null | PALBOCICLIB | 100073944 |
| 10388341 | 10064784 | 1.75 | 95 | Palliative (P) | 2020-08-06 | 2022-02-17 | Cisplatin + Vinorelbine (PO) | 02 | N | BUSULFAN | 100120971 |
| 10388440 | 10064785 | null | 68 | Palliative (P) | 2020-06-12 | 2020-07-31 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 101539323 |
| 10388489 | 10064786 | 1.82 | 48.9 | Palliative (P) | 2017-03-02 | 2017-03-02 | Bortezomib + Panobinostat | 2 | N | BORTEZOMIB + PANOBINOSTAT | 100070013 |
| 10388541 | 10064787 | 1.79 | 59 | Palliative (P) | 2020-07-12 | 2020-07-22 | Chlorambucil | 02 | N | CHLORAMBUCIL | 101400304 |
| 10388558 | 10064788 | 1.67 | 73.8 | Palliative (P) | 2019-06-01 | 2019-06-03 | DABRAFENIB | 02 | N | FLUOROURACIL | 100157464 |